RossiJ, PaczkowskiP, ShenY-W, et al.Preinfusion polyfunctional anti-CD19 chimeric antigen receptor T cells are associated with clinical outcomes in NHL. 2018; Blood, 132: 804–814.
2.
DarrahPA, PatelDT, De LucaPM, et al.Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. 2007; Nat. Med., 13: 843–850.
3.
SrivastavaSK, PanchSR, JinJ, et al.Abbreviated T-cell activation on the automated Clini-MACs prodigy device enhances bispecific CD19/22 chimeric antigen receptor T-cell viability and fold expansion, reducing total culture duration. 2018; Blood, 132: 4551.
